BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 10495070)

  • 1. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.
    Närhi TO; Meurman JH; Ainamo A
    Drugs Aging; 1999 Aug; 15(2):103-16. PubMed ID: 10495070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary gland hypofunction in elderly patients attending a xerostomia clinic.
    Longman LP; Higham SM; Rai K; Edgar WM; Field EA
    Gerodontology; 1995 Dec; 12(12):67-72. PubMed ID: 9084292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established and novel approaches for the management of hyposalivation and xerostomia.
    Wolff A; Fox PC; Porter S; Konttinen YT
    Curr Pharm Des; 2012; 18(34):5515-21. PubMed ID: 22632391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial.
    Hamada T; Nakane T; Kimura T; Arisawa K; Yoneda K; Yamamoto T; Osaki T
    Am J Med Sci; 1999 Sep; 318(3):146-51. PubMed ID: 10487404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dry mouth].
    Vidal E; Liozon E; Soria P
    Rev Prat; 2001 Jan; 51(2):148-54. PubMed ID: 11252939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between salivary flow rates, oral symptoms, and oral mucosal status.
    Kaplan I; Zuk-Paz L; Wolff A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):235-41. PubMed ID: 18417382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland hypofunction in patients with advanced cancer.
    Davies AN; Broadley K; Beighton D
    Oral Oncol; 2002 Oct; 38(7):680-5. PubMed ID: 12167420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reference guide to drugs and dry mouth--2nd edition.
    Sreebny LM; Schwartz SS
    Gerodontology; 1997 Jul; 14(1):33-47. PubMed ID: 9610301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
    Nieuw Amerongen AV; Veerman EC
    Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of photobiomodulation on salivary flow and composition, xerostomia and quality of life of patients during head and neck radiotherapy in short term follow-up: A randomized controlled clinical trial.
    Louzeiro GC; Cherubini K; de Figueiredo MAZ; Salum FG
    J Photochem Photobiol B; 2020 Aug; 209():111933. PubMed ID: 32570059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial.
    Piboonratanakit P; Ferreira JN; Pravinvongvuthi K; Maison K; Urkasemsin G; Boonroung T; Prayongrat A; Lertbutsayanukul C; Sucharitakul J; Vacharaksa A
    BMC Oral Health; 2023 May; 23(1):288. PubMed ID: 37179287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs.
    Plemons JM; Al-Hashimi I; Marek CL;
    J Am Dent Assoc; 2014 Aug; 145(8):867-73. PubMed ID: 25082939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cause, effects and treatment of hyposalivation].
    Vissink A; Jansma J; 's-Gravenmade EJ
    Ned Tijdschr Tandheelkd; 1992 Mar; 99(3):92-6. PubMed ID: 11819987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
    Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
    Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-induced hyposalivation: etiology, diagnosis, and treatment.
    Moore PA; Guggenheimer J
    Compend Contin Educ Dent; 2008; 29(1):50-5. PubMed ID: 18361341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction.
    Fox PC; van der Ven PF; Baum BJ; Mandel ID
    Oral Surg Oral Med Oral Pathol; 1986 Mar; 61(3):243-8. PubMed ID: 3517744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiologic factors of hyposalivation and consequences for oral health.
    Tschoppe P; Wolgin M; Pischon N; Kielbassa AM
    Quintessence Int; 2010 Apr; 41(4):321-33. PubMed ID: 20305867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians.
    Thomson WM; Chalmers JM; Spencer AJ; Ketabi M
    Spec Care Dentist; 1999; 19(1):20-3. PubMed ID: 10483456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era.
    Nittayananta W; Chanowanna N; Jealae S; Nauntofte B; Stoltze K
    J Oral Pathol Med; 2010 Jan; 39(1):28-34. PubMed ID: 19709350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study.
    Lakshman AR; Babu GS; Rao S
    J Cancer Res Ther; 2015; 11(1):229-33. PubMed ID: 25879367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.